Edition:
India

UK's MHRA Issues Drug Alert As GlaxoSmithKline Recalls All Unexpired Zantac Stock


Tuesday, 8 Oct 2019 

Oct 8 (Reuters) - Medicines and Healthcare products Regulatory Agency::UK'S MHRA SAYS ISSUED ALERT TO HEATHCARE PROFESSIONALS, AS GLAXOSMITHKLINE IS RECALLING ALL UNEXPIRED STOCK OF FOUR TYPES OF ZANTAC.UK'S MHRA SAYS RECALL IS PRECAUTIONARY MEASURE DUE TO POSSIBLE CONTAMINATION OF ACTIVE SUBSTANCE IN ZANTAC, RANITIDINE, WITH AN IMPURITY CALLED NDMA.